Guidelines established by the Quantitative Imaging Biomarkers Alliance (QIBA) Amyloid PET working group, co-chaired by Dawn Matthews of ADMdx and Anne Smith of Siemens Healthineers, have been published. The article in Journal of Neuroscience summarizes the multi-year work of the group, which defined criteria for PET image acquisition and measurement to reduce variability in results. […]

ADM Diagnostics, Inc. (ADMdx) has been awarded a two-year $1.96 million Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Aging (NIA) to develop a diagnostic test to detect the effects of repeated head impact upon the brain, and to differentiate these effects from Alzheimer's disease. Repeated sub-concussive impact to the […]

ADMdx has been awarded a new patent pertaining to a machine learning approach to differentiate brain effect patterns associated with multiple different diseases within the same brain scan. Patients often have more than one disease or syndrome that can cause cognitive impairment, such as the development of Alzheimer’s disease in a majority of adults with […]

Led by editors Dr. Jeffrey Cummings, Dr. Jeffrey Kinney and Dr. Howard Fillit, the book Alzheimer's Disease Drug Development: Research and Development Ecosystem has been published. Dawn Matthews, ADMdx CEO, was selected to be the primary author of the chapter on neuroimaging in Alzheimer’s Disease clinical trials. This book provides a comprehensive overview of the […]

In collaboration with Dr. Ana Pereira of Mount Sinai Medical Center and Rockefeller University, ADMdx studied the effects of the drug Riluzole upon brain metabolism and cognition in patients with Alzheimer’s Disease. In this study led by Dr. Pereira, Principal Investigator, FDG PET imaging was used to measure regional brain metabolism (which reflects neuronal function) before […]

ADM Diagnostics, Inc. has received FDA clearance for CorInsights MRI. Using a standard MRI scan, CorInsights MRI provides quantitative information about brain tissue volume for use by radiologists and neurologists, as well as clinical researchers. This information can help to provide important insight related to potential causes of symptoms such as cognitive impairment. This product […]